v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance (in share) at Dec. 31, 2024   9,377,259      
Beginning balance at Dec. 31, 2024 $ 160,415 $ 9 $ 426,724 $ 268 $ (266,586)
Exercises of stock options (in shares)   11,643      
Exercises of stock options 172   172    
Stock-based compensation expense 1,761   1,761    
Other comprehensive income (4)     (4)  
Net Income (Loss) (23,387)       (23,387)
Ending balance (in share) at Mar. 31, 2025   9,388,902      
Ending balance at Mar. 31, 2025 138,957 $ 9 428,657 264 (289,973)
Beginning balance (in share) at Dec. 31, 2024   9,377,259      
Beginning balance at Dec. 31, 2024 160,415 $ 9 426,724 268 (266,586)
Net Income (Loss) (49,157)        
Ending balance (in share) at Jun. 30, 2025   9,390,842      
Ending balance at Jun. 30, 2025 115,103 $ 9 430,660 177 (315,743)
Beginning balance (in share) at Mar. 31, 2025   9,388,902      
Beginning balance at Mar. 31, 2025 138,957 $ 9 428,657 264 (289,973)
Exercises of stock options (in shares)   1,940      
Exercises of stock options 5   5    
Stock-based compensation expense 1,998   1,998    
Other comprehensive income (87)     (87)  
Net Income (Loss) (25,770)       (25,770)
Ending balance (in share) at Jun. 30, 2025   9,390,842      
Ending balance at Jun. 30, 2025 $ 115,103 $ 9 430,660 177 (315,743)
Beginning balance (in share) at Dec. 31, 2025 9,417,295 9,417,295      
Beginning balance at Dec. 31, 2025 $ 51,439 $ 9 435,064 212 (383,846)
Exercises of stock options (in shares)   1,487      
Exercises of stock options 17   17    
Stock-based compensation expense 2,731   2,731    
Issuance of common stock in connection with the at-the-market program, net of offering costs, Share   501,861      
Issuance of common stock in connection with the at-the-market program, net of offering costs 5,020   5,020    
Issuance of common stock and pre-funded warrants in connection with the private placement, net of offering costs, Share   4,501,928      
Issuance of common stock and pre-funded warrants in connection with the private placement, net of offering costs 80,258 $ 5 80,253    
Other comprehensive income (207)     (207)  
Net Income (Loss) (19,625)       (19,625)
Ending balance (in share) at Mar. 31, 2026   14,422,571      
Ending balance at Mar. 31, 2026 $ 119,633 $ 14 523,085 5 (403,471)
Beginning balance (in share) at Dec. 31, 2025 9,417,295 9,417,295      
Beginning balance at Dec. 31, 2025 $ 51,439 $ 9 435,064 212 (383,846)
Exercises of stock options (in shares) 1,487        
Net Income (Loss) $ (38,541)        
Ending balance (in share) at Jun. 30, 2026 14,705,646 14,705,646      
Ending balance at Jun. 30, 2026 $ 103,226 $ 14 525,788 (189) (422,387)
Beginning balance (in share) at Mar. 31, 2026   14,422,571      
Beginning balance at Mar. 31, 2026 119,633 $ 14 523,085 5 (403,471)
Stock-based compensation expense 2,703   2,703    
Vesting of restricted stock units   233,075      
Vesting of performance stock units   50,000      
Other comprehensive income (194)     (194)  
Net Income (Loss) $ (18,916)       (18,916)
Ending balance (in share) at Jun. 30, 2026 14,705,646 14,705,646      
Ending balance at Jun. 30, 2026 $ 103,226 $ 14 $ 525,788 $ (189) $ (422,387)